Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes-Reference-Cited by-同舟云学术

Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes

Published:2021-06-23 Issue:19 Volume:127 Page:3552-3565
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kanagal‐Shamanna Rashmi¹^ORCID,Montalban‐Bravo Guillermo²,Sasaki Koji²^ORCID,Darbaniyan Faezeh³,Jabbour Elias²^ORCID,Bueso‐Ramos Carlos¹,Wei Yue²,Chien Kelly²,Kadia Tapan²^ORCID,Ravandi Farhad²,Borthakur Gautam²,Soltysiak Kelly A.²,Routbort Mark¹,Patel Keyur¹,Pierce Sherry²,Medeiros L. Jeffrey¹,Kantarjian Hagop M.²^ORCID,Garcia‐Manero Guillermo²^ORCID

Affiliation:

1. Department of Hematopathology The University of Texas MD Anderson Cancer Center Houston Texas

2. Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas

3. Department of Biostatistics The University of Texas MD Anderson Cancer Center Houston Texas

Funder

Ladies Leukemia League

NIH Clinical Center

University of Texas MD Anderson Cancer Center

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33745

Reference29 articles.

1. Clinical and biological implications of driver mutations in myelodysplastic syndromes

2. SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts

3. SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts

4. Frequent pathway mutations of splicing machinery in myelodysplasia

5. Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological relevance of alternative splicing in hematologic malignancies;Molecular Medicine;2024-05-17

2. Roles and mechanisms of aberrant alternative splicing in melanoma — implications for targeted therapy and immunotherapy resistance;Cancer Cell International;2024-03-10

3. Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissue: Myeloid Neoplasms;Modern Pathology;2024-02

4. Clonal Hematopoiesis, Inflammation, and Hematologic Malignancy;Annual Review of Pathology: Mechanisms of Disease;2024-01-24

5. Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes;HemaSphere;2023-10